H1UM34 Stock Overview
Provides medical and specialty insurance products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Humana Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$38.12 |
| 52 Week High | US$56.56 |
| 52 Week Low | US$26.25 |
| Beta | 0.52 |
| 11 Month Change | 16.26% |
| 3 Month Change | -11.10% |
| 1 Year Change | -31.98% |
| 33 Year Change | -34.56% |
| 5 Year Change | n/a |
| Change since IPO | 17.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| H1UM34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 7.1% | -4.8% | -0.8% |
| 1Y | -32.0% | -18.7% | -2.9% |
Return vs Industry: H1UM34 underperformed the BR Healthcare industry which returned -16.3% over the past year.
Return vs Market: H1UM34 underperformed the BR Market which returned -1.7% over the past year.
Price Volatility
| H1UM34 volatility | |
|---|---|
| H1UM34 Average Weekly Movement | 8.5% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.2% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: H1UM34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: H1UM34's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 67,600 | Jim Rechtin | www.humana.com |
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals.
Humana Inc. Fundamentals Summary
| H1UM34 fundamental statistics | |
|---|---|
| Market cap | R$205.77b |
| Earnings (TTM) | R$7.90b |
| Revenue (TTM) | R$668.56b |
26.2x
P/E Ratio0.3x
P/S RatioIs H1UM34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| H1UM34 income statement (TTM) | |
|---|---|
| Revenue | US$115.01b |
| Cost of Revenue | US$98.07b |
| Gross Profit | US$16.95b |
| Other Expenses | US$15.59b |
| Earnings | US$1.36b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 29, 2025
| Earnings per share (EPS) | 11.29 |
| Gross Margin | 14.73% |
| Net Profit Margin | 1.18% |
| Debt/Equity Ratio | 75.9% |
How did H1UM34 perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield32%
Payout RatioDoes H1UM34 pay a reliable dividends?
See H1UM34 dividend history and benchmarks| Humana dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Feb 06 2025 |
| Days until Ex dividend | 35 days |
| Days until Dividend pay date | 76 days |
Does H1UM34 pay a reliable dividends?
See H1UM34 dividend history and benchmarks